treatment for patients with skin cancer / blood products / cancer therapy / treatment of cancer / /
MedicalCondition
cancer / suitable solid tumours / skin cancer / infectious agents / tumour / metastatic melanoma / /
MedicalTreatment
surgery / cancer therapy / /
Organization
office of the Gene Technology Regulator Website / office of the Gene Technology Regulator / Department of Agriculture / Therapeutic Goods Administration / / /
Questions & Answers on licence application DIR 132 – Commercial release of a tumour-selective genetically modified virus for cancer therapy What is this application for? Amgen Australia Pty Ltd (Amgen) is seeking appro